Normothermic Machine Perfusion of Pediatric Donors: Meeting the Unmet Need in Pediatric Liver Transplantation
* You will be redirected to the BCM DCPD credit management site when claiming credit and may be asked to register or log in.
In this presentation, Dr. Chun-Sing (Kevin) Huang discusses the evolution of organ preservation practices in transplantation surgery, including the current use of University of Wisconsin solution as the gold standard for static cold storage. He also highlights the potential role for machine perfusion to help fill the unmet needs of the liver transplant waitlist.
This Michael E. DeBakey Department of Surgery Grand Rounds session took place on Wednesday, December 10, 2025 at 7:00 a.m.
Activity Information
How to Claim Credit
You may claim credit after watching this activity.
You will be redirected to the BCM DCPD credit management site when claiming credit and may be asked to register or log in.
Needs Statement
There is a clear need for training healthcare providers on the use of SIMPL (Society for Improving and Measuring Procedural Learning) as a computer or mobile-accessible evaluation tool. Education should focus on how to conduct timely, structured feedback sessions immediately following surgical procedures. Learners must understand the value of direct feedback in enhancing procedural learning and clinical performance. Additionally, educators need guidance on implementing best practices for formative feedback to ensure consistency and effectiveness across the department.
Educational Objectives
At the conclusion of the activity, the participants should be able to:
- Describe the history of organ preservation, and the gold standard of UW solution for static cold storage.
- Identify the unmet need for organs for pediatric donors with roughly 200 additional livers needed every year to meet the need of the waitlist.
- Distinguish the potential role for machine perfusion to utilize donation after cardiac death donors.
Target Audience
Professional Categories
- Physicians
- Medical Students
- Fellows
- Residents
- Other Health Professionals
Specialties
- Pediatrics
- Surgery
- Transplant Surgery
Interest Groups
- Artificial Intelligence and Technology
Activity Evaluation
Evaluation by questionnaire will address program content, presentation, and possible bias.
Educational Methods
- Lectures
- Case Presentations
- Literature Review
- Panel Discussion
Accreditation/Credit Designation
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Activity Directors
-
-
James W. Suliburk, M.D., FACS
Associate Professor and Chief, Endocrine Surgery
Baylor College of Medicine
Term of Approval
December 1, 2025 through December 31, 2027. Original release date: December 1, 2025.
Disclosure Policy
Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.
In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.
In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.
BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:
Presenter
-
Chun-Sing Huang, M.D.
General Surgery Resident
Baylor College of Medicine
Disclosure:
- Consultancy: TransMedics Speaker
- Honorarium Recipient: TransMedics
Activity Directors
-
Michele Loor, M.D., FACS
Associate Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
James W. Suliburk, M.D., FACS
Associate Professor and Chief, Endocrine Surgery
Baylor College of Medicine
Disclosure:
- Consultancy: Ascendis Pharmaceuticals; Corcept Pharmaceuticals
- Intellectual Property (patent rights, royalty payments): Inspectra Diagnostics; MasSpec Pen Technologies
Planning Committee Members
-
William E Fisher, M.D., FACS
Professor, Clinical Vice-Chair and Chief, Division of General Surgery
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
John A Goss, M.D.
Professor of Surgery and Chief, Division of Abdominal Transplantation
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Shawn Groth, M.D.
Associate Professor of Surgery
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Michele Loor, M.D., FACS
Associate Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Todd Rosengart, M.D., MBA, FACS
DeBakey-Bard Chair of Surgery
Baylor College of Medicine
Disclosure:
- Consultancy: XyloCor Therapeutics
- Board Membership: XyloCor Therapeutics; Geoclin Therapeutics
- Ownership Interests (stock, stock options, excluding diversified mutual funds): XyloCor Therapeutics; Geoclin Therapeutics
-
James W. Suliburk, M.D., FACS
Associate Professor and Chief, Endocrine Surgery
Baylor College of Medicine
Disclosure:
- Consultancy: Ascendis Pharmaceuticals; Corcept Pharmaceuticals
- Intellectual Property (patent rights, royalty payments): Inspectra Diagnostics; Mass Spec Pen Technologies